A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Recruiting

Phase 2

AAV2-hAQP1 Gene TherapyA Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Sponsor:

MeiraGTx, LLC

Code:

NCT05926765

Conditions

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AAV2-hAQP1 Concentration 1

AAV2-hAQP1 Concentration 2

Placebo

AAV2-hAQP1 Concentration 3

AAV2-hAQP1 Concentration 4

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-15. This information was provided to ClinicalTrials.gov by MeiraGTx, LLC on 2025-08-26.